Literature DB >> 29992553

Breast cancer in women living with HIV: A first global estimate.

Valerie A McCormack1, Olivia Febvey-Combes1, Ophira Ginsburg2, Isabel Dos-Santos-Silva3.   

Abstract

There is a growing population of older women living with HIV/AIDS (WLWHA). Breast cancer is a common cancer in women worldwide, but the global number of breast cancers in WLWHA is not known. We estimated, for each UN sub-region, the number and age distribution of WLWHA who were diagnosed with breast cancer in 2012, by combining IARC-GLOBOCAN estimates of age-country specific breast cancer incidence with corresponding UNAIDS HIV prevalence. Primary analyses assumed no HIV-breast cancer association, and a breast cancer risk reduction scenario was also considered. Among 16.0 million WLWHA aged 15+ years, an estimated 6,325 WLWHA were diagnosed with breast cancer in 2012, 74% of whom were in sub-Saharan Africa, equally distributed between Eastern, Southern and Western Africa. In most areas, 70% of HIV-positive breast cancers were diagnosed under age 50. Among all breast cancers (regardless of HIV status), HIV-positive women constituted less than 1% of the clinical burden, except in Eastern, Western and Middle Africa where they comprised 4-6% of under age 50 year old breast cancer patients, and in Southern Africa where this patient subgroup constituted 26 and 8% of breast cancers diagnosed under and over age 50 respectively. If a deficit of breast cancer occurs in WLWHA, the global estimate would reduce to 3,600. In conclusion, worldwide, the number of HIV-positive women diagnosed with breast cancer was already substantial in 2012 and with an expected increase within the next decade, early detection and treatment research targeted to this population are needed.
© 2018 UICC.

Entities:  

Keywords:  Africa; HIV; breast cancer

Mesh:

Year:  2018        PMID: 29992553     DOI: 10.1002/ijc.31722

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  Mapping Evidence on the Burden of Breast, Cervical, and Prostate Cancers in Sub-Saharan Africa: A Scoping Review.

Authors:  Alfred Musekiwa; Maureen Moyo; Mohanad Mohammed; Zvifadzo Matsena-Zingoni; Halima Sumayya Twabi; Jesca Mercy Batidzirai; Geoffrey Chiyuzga Singini; Kabelo Kgarosi; Nobuhle Mchunu; Portia Nevhungoni; Patricia Silinda; Theodora Ekwomadu; Innocent Maposa
Journal:  Front Public Health       Date:  2022-06-16

2.  Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy.

Authors:  Yehoda M Martei; Mohan Narasimhamurthy; Dipho I Setlhako; Gezahen Ayane; Tlotlo Ralefala; Sebathu Chiyapo; Robert Gross; Lawrence N Shulman; Surbhi Grover; Angela DeMichele
Journal:  JCO Glob Oncol       Date:  2022-05

3.  Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC.

Authors:  Amanda Blair Spence; Matthew E Levy; Anne Monroe; Amanda Castel; Joseph Timpone; Michael Horberg; Lucile Adams-Campbell; Princy Kumar
Journal:  J Community Health       Date:  2021-02

Review 4.  The effect of non-AIDS-defining cancers on people living with HIV.

Authors:  Elizabeth Y Chiao; Anna Coghill; Darya Kizub; Valeria Fink; Ntokozo Ndlovu; Angela Mazul; Keith Sigel
Journal:  Lancet Oncol       Date:  2021-06       Impact factor: 54.433

5.  Inequities in breast cancer treatment in sub-Saharan Africa: findings from a prospective multi-country observational study.

Authors:  Milena Foerster; Benjamin O Anderson; Fiona McKenzie; Moses Galukande; Angelica Anele; Charles Adisa; Annelle Zietsman; Joachim Schuz; Isabel Dos Santos Silva; Valerie McCormack
Journal:  Breast Cancer Res       Date:  2019-08-13       Impact factor: 6.466

Review 6.  The Evolution of Pharmacological Activities Bouea macrophylla Griffith In Vivo and In Vitro Study: A Review.

Authors:  Intan Tsamrotul Fu'adah; Sri Adi Sumiwi; Gofarana Wilar
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-16

7.  Disparities in breast cancer survival between women with and without HIV across sub-Saharan Africa (ABC-DO): a prospective, cohort study.

Authors:  Steady Chasimpha; Valerie McCormack; Herbert Cubasch; Maureen Joffe; Annelle Zietsman; Moses Galukande; Groesbeck Parham; Leeya F Pinder; Angelica Anele; Charles A Adisa; Awa Ukonye Offiah; Benjamin O Anderson; Pauline Boucheron; Milena Foerster; Joachim Schüz; Isabel Dos-Santos-Silva
Journal:  Lancet HIV       Date:  2022-03       Impact factor: 16.070

8.  Preexisting morbidity profile of women newly diagnosed with breast cancer in sub-Saharan Africa: African Breast Cancer-Disparities in Outcomes study.

Authors:  Oluwatosin A Ayeni; Shane A Norris; Maureen Joffe; Herbert Cubasch; Moses Galukande; Annelle Zietsman; Groesbeck Parham; Charles Adisa; Angelica Anele; Joachim Schüz; Benjamin O Anderson; Milena Foerster; Isabel Dos Santos Silva; Valerie A McCormack
Journal:  Int J Cancer       Date:  2020-11-25       Impact factor: 7.316

9.  A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection.

Authors:  Sarah Nietz; Daniel S O'Neil; Oluwatosin Ayeni; Wenlong Carl Chen; Maureen Joffe; Judith S Jacobson; Alfred I Neugut; Paul Ruff; Witness Mapanga; Ines Buccimazza; Urishka Singh; Sharon Čačala; Laura Stopforth; Boitumelo Phakathi; Tobias Chirwa; Herbert Cubasch
Journal:  Breast Cancer Res Treat       Date:  2020-09-01       Impact factor: 4.872

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.